About the Mouse & Cell Line Portfolio

Cancer Research Technology (CRT) has been successfully commercialising research reagents created in academic institutes for over 20 years. Our track record is built on dedicated, experienced reagent sales personnel, efficient production and distribution facilities and support from in-house marketing, finance and legal teams.

CRT has exclusive rights to commercialise mouse models and cell lines created in programmes funded by Cancer Research UK, giving licencees access to a diverse and well-characterised catalogue. Our portfolio has a strong emphasis on cancer research and oncology, however we also maintain mouse models and cell lines with applications in a broad range of human disease and preclinical research. All our mouse models are unique, and are exclusively available from Cancer Research Technology.

Browse the Mouse & Cell Line Portfolio

Here you can find information on the extensive range of mouse models and cell lines available from CRT, our terms and conditions of supply, and our flexible business models.

You can browse the mouse and cell line portfolio by type and application of model, by disease keyword, or by phenotype keyword (for mice) by selecting from the options below.

We can supply mouse models and cell lines direct to you for use in research and development. In addition, we offer licences for the provision of contract research services, and for the right to sublicence.

General information on supply, pricing and terms and conditions can be found here.